Canada Disposable Syringes Market Research Report, 2030

Imagine a time when nurses in Canada had to boil heavy glass syringes after every single use long before the idea of single-use syringes became a medical norm across North America and beyond. The journey of the disposable syringe in Canada began in the mid-20th century when hospitals and public health institutions struggled with infection control, especially in remote and underserved regions. In response, the introduction of plastic, single-use syringes in the 1950s completely changed how medical professionals administered care. Initially developed to tackle the high infection rates linked to reusable equipment, these syringes brought sterilization, safety, and speed to the forefront of patient treatment. Canadian healthcare institutions, ranging from urban hospitals to rural clinics in the northern provinces, quickly adopted this innovation due to its practicality. Technically, a disposable syringe is a single-use plastic medical device used to administer drugs or extract bodily fluids, composed of a sterile needle, a clear barrel, and a plunger all individually packaged to avoid contamination. It solves critical problems like reducing the risk of transmitting HIV, hepatitis, and other blood-borne diseases. It also saves time and labor previously spent on sterilization, while making healthcare safer for both patients and providers. Over time, companies invested in advanced safety mechanisms like needle retractability, tamper-proof features, and ergonomic designs to accommodate various users from trained professionals to at-home patients. But this growth hasn’t come without challenges in the Canadian context. One major issue is the environmental impact caused by the volume of discarded plastic waste. Another is the high production and regulatory costs that smaller domestic manufacturers face, especially when competing with global suppliers. Additionally, counterfeit products entering through unregulated channels threaten the quality and safety of care. According to the research report, "Canada Disposable Syringe Converter Market Research Report, 2030," published by Actual Market Research, the Canada Disposable Syringe Market is anticipated to add to more than USD 130 Million by 2025–30. In Canada, the disposable syringe market is driven by several strong forces, including the nation’s aging population, a rise in chronic conditions such as diabetes and arthritis, and federal healthcare programs that support widespread vaccination and harm reduction initiatives. The demand is also fueled by public health policies encouraging the use of sterile, single-use medical tools to prevent infectious disease outbreaks. Recent developments include the introduction of safety-engineered syringes designed specifically to prevent accidental needle-stick injuries, and innovative biodegradable syringes aimed at reducing environmental impact. Major players in the Canadian market include international brands like Becton, Dickinson and Company, and Terumo, along with local suppliers such as Vita Needle and Canadian Hospital Specialties, offering a wide range of syringes including auto-disable and retractable types to suit hospitals, vaccination centers, and home care settings. These companies supply to meet national safety standards and help healthcare institutions comply with infection control regulations. Opportunities lie in expanding access to safe injection equipment in rural and Indigenous communities and in integrating digital health tools with syringe delivery, such as dose-tracking apps and smart packaging. Compliances and certifications like Health Canada’s medical device license, ISO 13485, and adherence to the Medical Device Single Audit Program (MDSAP) ensure these products meet stringent safety, manufacturing, and labeling standards. These protocols reduce the likelihood of product recalls and promote patient safety. Among the emerging trends are government-funded needle exchange programs that use high volumes of disposable syringes, eco-conscious procurement strategies emphasizing sustainable packaging, and the integration of digital tech in supply chain monitoring.

What's Inside a Actual Market Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

The disposable syringe market in Canada by type is shaped largely by two main categories conventional syringes and safety syringes, both of which hold vital importance in healthcare delivery across the country. Conventional syringes have traditionally been the cornerstone of injection devices in Canadian medical settings, prized for their simplicity and cost-effectiveness. These syringes consist of a transparent plastic barrel, a smooth plunger, and a finely sharpened needle, all designed for one-time use to prevent infections and contamination. Their ease of use and availability make them indispensable not only in hospitals and clinics but also in long-term care facilities and community health centers. However, in response to rising concerns over occupational safety and needle-stick injuries among healthcare workers, Canada has seen a significant shift toward safety syringes. Safety syringes are engineered with advanced features such as retractable needles, needle guards, or auto-disable mechanisms that activate immediately after use to prevent reuse and accidental injuries. Canadian health authorities and regulatory bodies have implemented strict guidelines that encourage the adoption of these safety devices, aiming to reduce workplace hazards and improve patient safety standards. The coexistence of conventional and safety syringes in the market illustrates Canada’s careful balance between maintaining cost efficiency and advancing protective measures. Healthcare providers often select the appropriate syringe type depending on clinical needs, budget constraints, and regulatory compliance, which fosters a dynamic, evolving market landscape in the country. Disposable syringes serve two fundamental medical purposes immunization injections and therapeutic injections, both of which are critical to the nation’s public health infrastructure. Immunization injections drive a substantial portion of demand due to Canada’s comprehensive vaccination programs targeting diseases such as seasonal influenza, measles, mumps, rubella, HPV, and the recent COVID-19 pandemic. These programs require syringes that not only guarantee sterility but also enable precise dosing and safe handling by healthcare workers in various settings, from large urban hospitals to mobile immunization clinics in rural and Indigenous communities. The emphasis on safety and efficiency during mass vaccination campaigns has propelled innovations in syringe design, including the increased use of prefilled syringes and auto-disable mechanisms to prevent needle reuse. On the therapeutic side, disposable syringes are essential for administering medications to treat chronic conditions like diabetes, arthritis, and multiple sclerosis, as well as acute treatments such as pain management and emergency care. The rising trend of outpatient care and patient self-administration of injectable therapies at home has further expanded the therapeutic segment, prompting manufacturers to develop syringes with ergonomic grips, reduced injection pain features, and better dosage accuracy. This wide application scope ensures disposable syringes remain indispensable across all levels of the Canadian healthcare system, supporting both preventive measures and ongoing treatment regimens with safety and reliability. The end-user segment of Canada’s disposable syringe market encompasses hospitals, diagnostic laboratories, blood banks, and other sectors including the pharmaceutical industry, which increasingly relies on prefilled syringes for drug delivery and clinical trials. Hospitals represent the largest group of end users due to the sheer volume and variety of injections performed daily, spanning surgical procedures, vaccination drives, anesthesia administration, and routine medication delivery. These healthcare facilities demand syringes that meet stringent standards for sterility, safety, and ease of use to protect both patients and staff. Diagnostic laboratories depend on disposable syringes to safely and accurately collect blood and other biological samples necessary for testing, research, and disease monitoring. Blood banks utilize syringes extensively during blood donation drives and transfusion procedures, where precision and contamination prevention are critical for patient safety. The pharmaceutical sector’s growing use of prefilled syringes also shapes the market by providing ready-to-use injectable medicines that minimize preparation time, reduce dosing errors, and improve overall safety during drug administration. Each of these end-user categories has distinct requirements, driving continuous innovation in syringe materials, needle design, safety features, and packaging solutions. The diverse demands across end users create a vibrant market ecosystem in Canada, encouraging manufacturers and suppliers to focus on product quality, safety enhancements, and technological advancement to meet the evolving needs of healthcare professionals and patients alike.

Make this report your own

We're excited to discuss your needs and our solutions. Let's schedule a call.

Ask an Expert

Nikita Jabrela

Business Development Manager

Considered in this report • Historic Year: 2019 • Base year: 2024 • Estimated year: 2025 • Forecast year: 2030 Aspects covered in this report • Disposable Syringes Market with its value and forecast along with its segments • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation By Type • Conventional Syringes • Safety Syringes

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

By Application • Immunization Injections • Therapeutic Injections By End User • Hospitals • Diagnostic Laboratories • Blood Banks • Others (Pharmaceutical Industry (B2B) (Prefilled Syringes)) The approach of the report: This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and listing out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, annual report of companies, analyzing the government generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducted trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers in regional aspects, tier aspects, age group, and gender. Once we have primary data with us we have started verifying the details obtained from secondary sources. Intended audience This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to this industry, government bodies and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.